S. L. Nakonechnaya

S. L. Nakonechnaya

Auto-generated profile, based on publicly available information

S. L. Nakonechnaya

National Medical Research Center for Phthisiopulmonology and Infectious Diseases

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2021 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
OBO. D. Baronova
O. D. Baronova
VAV. A. Aksenova
V. A. Aksenova
LBL. A. Baryshnikova
L. A. Baryshnikova
DKDmitry Kudlay
Dmitry Kudlay
SNS. L. Nakonechnaya
S. L. Nakonechnaya
Introduction. In the context of a decrease in the tension of the epidemic situation on tuberculosis in Russia, it remains relevant to search for new ways to increase the effectiveness of preventive anti-tuberculosis measures among children and teenagers, taking into account an integrated approach to assessing all risk factors for tuberculosis in various age groups of the child population.Objective. Tо study the complex characteristics of groups at increased risk of tuberculosis among children of different ages who have positive results of a skin test with a recombinant tuberculous allergen (АТR).Materials and methods. The study retrospectively included 392 patients aged 2–17 years with a positive ATR test result. The рatients were randomized by age into 3 groups: in the 1st group there were 87 children 2–7 years old, in the 2nd group 182 children aged 8–14 years were included, in the 3rd group included 121 patients 15–17 years. The children did not have clinical and radiological signs of active tuberculosis and were HIV-negativ.Result. Among children and adolescents with a positive result of the test with ATR, social risk factors for developing tuberculosis (unfavorable living conditions, lack of permanent employment in 86.3% of parents) were determined. It was found that children living in families with low social status were dominated by contact with patients with multidrug resistance of the pathogen (MDR-TB), more than half of children (53.1%) had comorbidities. In 13.3% of children, small calcifications were detected in the lungs, in the intrathoracic lymph nodes.Conclusion. Among children 2–7 years old with positive results of the test with ATR, a complex of risk factors for the development of tuberculosis prevails: low material security in every second family, alcohol and drug dependence of parents in every third family, contact with MDR-TB patients in 56.5% of children, high incidence of concomitant pathology (in 67.4% of children).

30 October 2021 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
VAV. A. Aksenova
V. A. Aksenova
NKN. I. Klevno
N. I. Klevno
AKAlexey Владимирович Kazakov
Alexey Владимирович Kazakov
DKDmitry Kudlay
Dmitry Kudlay
APA. D. Pakhlavonova
A. D. Pakhlavonova
SNS. L. Nakonechnaya
S. L. Nakonechnaya
Introduction. The treatment of children with multidrug-resistant and extensively drug-resistant tuberculosis (MDR / XDR-TB) is a difficult task due to many factors: the duration of treatment, the lack of drugs with children’s dosages, age restrictions (according to the drug instructions).Purpose of the study. To assess the efficacy and safety of regimen with the inclusion of bedaquiline in children and adolescent with respiratory tuberculosis with drug-resistant tuberculosis.Materials and methods. The study is prospective, cohort, non-comparative from the period 2017–2019. We included 24 patients aged 5 to 17 years with MDR-TB (established or suspected) began regimen containing bedaquiline for 24 weeks. The duration of observation of patients included in the study was 24 months.Results. We can state a sufficient level of safety of using the latter for 24 weeks: adverse events presumably associated directly with the intake of bedaquiline were noted in only 1 patient out of 24 (4.2%; 95% CI 0.7-20.3). The efficacy of a regimen containing bedaquiline in combination with other anti-tuberculosis reserve drugs is beyond doubt: positive clinical and radiological dynamics and cessation of bacterial excretion by the end of the 24-week course of treatment were noted in all patients included in the study. In the course of 2-year follow-up, no exacerbation of the tuberculous process was observed in any case. All patients achieved clinical cure of tuberculosis.Conclusion. Regimen containing bedaquiline for children aged 5–17 years with multidrug-resistant tuberculosis is effective and safe.

12 March 2025 in Tuberculosis and Lung Diseases
Verified
Journal Article
Open access
PDF file
VAV. A. Aksenova
V. A. Aksenova
SNS. L. Nakonechnaya
S. L. Nakonechnaya
YMYu. L. Mizernitskiy
Yu. L. Mizernitskiy
NKN. I. Klevno
N. I. Klevno
AKA. V. Kazakov
A. V. Kazakov
ЮМЮ. Л. Мизерницкий
Ю. Л. Мизерницкий
The objective: to determine the most significant parameters in the diagnosis of tuberculosis in children with chronic non-specific lung diseases in order to form groups facing a high risk of developing tuberculosis.Subject and Methods: 236 children were enrolled in the study, who were divided into three groups: TB+CNSLD group – 65 children with primary tuberculosis and concomitant chronic non-specific respiratory disease, TB group - 93 children with active respiratory tuberculosis and a group of 78 children and adolescents with chronic non-specific respiratory diseases without tuberculosis but infected with MTB.Results. Chronic non-specific lung diseases increase the risk of earlier development of tuberculosis in children. For the first time, effectiveness of IGRA tests and TRA tests for detecting tuberculosis in children infected with tuberculous mycobacteria with both allergic and infectious-inflammatory non-specific lung diseases has been proven.

21 September 2022 in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
Verified
Journal Article
Closed access
PDF file
SNS. L. Nakonechnaya
S. L. Nakonechnaya
VAV. A. Aksenova
V. A. Aksenova
YMYu. L. Mizernitskiy
Yu. L. Mizernitskiy
ЮМЮ. Л. Мизерницкий
Ю. Л. Мизерницкий
The problem of the combination of tuberculosis and chronic nonspecific diseases of the bronchopulmonary system in children and adolescents has not been sufficiently studied to date and remains relevant.Purpose. The study aims at determination of predictors of tuberculosis infection to identify groups at high risk of developing tuberculosis among children with chronic nonspecific pathology.Materials and research methods. A prospective study of children and adolescents (n = 158) with isolated respiratory tuberculosis and its combination with various forms of chronic obstructive pulmonary disease (lung defects, chronic bronchitis, bronchial asthma) was conducted. These two groups were compared in respect of the medical history and physical examination data, as well as computed tomography findings.Results. The predictors of the development of tuberculosis included cases of pneumonia at an early age, acute respiratory infections 3 or more times a year, and the early age of children infected with Mycobacterium tuberculosis.Conclusion. These conditions increase the risk of developing active tuberculosis in children and cause its more severe course. In addition, chronic nonspecific lung diseases associated with tuberculosis often complicate the course of a specific process and are often characterized by recurrent attacks.

17 January 2023 in Pacific Medical Journal
Verified
Journal Article
Open access
PDF file
SNS. L. Nakonechnaya
S. L. Nakonechnaya
VAV. A. Aksenova
V. A. Aksenova
YMYu. L. Mizernitskiy
Yu. L. Mizernitskiy
ЮМЮ. Л. Мизерницкий
Ю. Л. Мизерницкий
Aim. Selection and combination of immunodiagnostic tests to detect active tuberculosis (TB) in children with concomitant bronchopulmonary pathologies.Materials and methods. A prospective study of children and adolescents (n = 236) was conducted, which included cases with localized pulmonary tuberculosis; pulmonary tuberculosis associated with allergic or infectious and inflammatory forms of chronic nonspecific lung diseases (CNSLD); chronic nonspecific lung diseases under a significant absence of active TB but the presence of Mycobacterium tuberculosis. All patients underwent immunodiagnostic tests by Mantoux test, recombinant tuberculosis allergen (RTA) test, and QuantiFERON – GIT.Results. Mantoux and RTA tests were found to exhibit high sensitivity in children both with tuberculosis associated with concomitant pathologies and without such pathologies. Differences were observed in the results obtained by the Mantoux test in children with tuberculosis-associated bronchopulmonary pathology and those with localized tuberculosis. The Mantoux test may be positive as a result of many factors, other than active TB infection. Thus, children with allergic and infectious-inflammatory pathologies of the lungs exhibit an altered sensitivity to the Mantoux test. Such cases require in vitro diagnostics with the Quanti- FERON test, whose sensitivity is high despite the presence of CNSLD.Conclusions. Children with infectious-inflammatory CNSLD should undergo TB examination in stages based on in vivo and in vitro tests, when necessary. Children with allergic CNSLD should undergo in vitro tests at the first stage.